Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fixed‐dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications
Donald J. DiPette, Jamario Skeete, Emily Ridley, et al.
Journal of Clinical Hypertension (2018) Vol. 21, Iss. 1, pp. 4-15
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Utilizing graph machine learning within drug discovery and development
Thomas Gaudelet, Ben Day, Arian R. Jamasb, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 185
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features
Christi A. Wilkins, Hannlie Hamman, Josias H. Hamman, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 178-178
Open Access | Times Cited: 18
Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005–2016
Catherine G. Derington, Jordan B. King, Jennifer S. Herrick, et al.
Hypertension (2020) Vol. 75, Iss. 4, pp. 973-981
Open Access | Times Cited: 99
HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care
Pedro Ordúñez, Norm R.C. Campbell, Gloria P Giraldo Arcila, et al.
Revista Panamericana de Salud Pública (2022) Vol. 46, pp. 1-1
Open Access | Times Cited: 39
WHO HEARTS: A Global Program to Reduce Cardiovascular Disease Burden: Experience Implementing in the Americas and Opportunities in Canada
Norm R.C. Campbell, Pedro Ordúñez, Gloria Giraldo, et al.
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 5, pp. 744-755
Closed Access | Times Cited: 67
Fixed-dose combination antihypertensive medications
Ivor J. Benjamin, Reinhold Kreutz, Michael Hecht Olsen, et al.
The Lancet (2019) Vol. 394, Iss. 10199, pp. 637-638
Open Access | Times Cited: 62
Scaling up effective treatment of hypertension—A pathfinder for universal health coverage
Thomas R. Frieden, Cherian Varghese, Sandeep P. Kishore, et al.
Journal of Clinical Hypertension (2019) Vol. 21, Iss. 10, pp. 1442-1449
Open Access | Times Cited: 46
Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative
Donald J. DiPette, Kenneth Goughnour, Eric Zúñiga, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 12, pp. 2285-2295
Open Access | Times Cited: 43
Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost
Abdul Salam, Mark D. Huffman, Raju Kanukula, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 10, pp. 1769-1779
Open Access | Times Cited: 40
Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension
Huynh Van Minh, Huy Tran, Long Doan, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 9, pp. 1121-1138
Open Access | Times Cited: 24
Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis
Qiran Wei, Jiting Zhou, Hongchao Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control
Pedro Ordúñez, Norm R.C. Campbell, Donald J. DiPette, et al.
Current Hypertension Reports (2023) Vol. 26, Iss. 4, pp. 141-156
Open Access | Times Cited: 14
Single-pill combination for treatment of hypertension: Just a matter of practicality or is there a real clinical benefit?
António Coca, SP Whelton, Miguel Camafort, et al.
European Journal of Internal Medicine (2024) Vol. 126, pp. 16-25
Open Access | Times Cited: 5
Implementing integrated hypertension and diabetes management using the World Health Organization’s HEARTS model: protocol for a pilot study in the Guatemalan national primary care system
Irmgardt Alicia Wellmann, Luis Fernando Ayala, José Javier Rodríguez, et al.
Implementation Science Communications (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
A Quantitative Analysis of Aspirin, Telmisartan, and Bisoprolol in Spiked Human Plasma Using Green Spectrofluorimetric Analysis
Osama I. Abdel Sattar, Hamed H. M. Abuseada, Sherif Ramzy, et al.
Luminescence (2025) Vol. 40, Iss. 3
Closed Access
Acceptability of fixed-dose combination treatments for hypertension in Kenya: A qualitative study using the Theoretical Framework of Acceptability
Daniel Mbuthia, Ruth Willis, Mary Gichagua, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 3, pp. e0003012-e0003012
Open Access
HEARTS Pharmacy: A framework for integrating pharmacists in hypertension and cardiovascular disease risk management in primary care
Emily Ridley, Donald J. DiPette, Stephanie Gysel, et al.
Revista Panamericana de Salud Pública (2025) Vol. 49, pp. 1-1
Open Access
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial
Thomas Lung, Stephen Jan, H Asita de Silva, et al.
The Lancet Global Health (2019) Vol. 7, Iss. 10, pp. e1359-e1366
Open Access | Times Cited: 34
Position statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017–2020
Fernando Wyss, António Coca, Patricio López‐Jaramillo, et al.
International Journal of Cardiology Hypertension (2020) Vol. 6, pp. 100041-100041
Open Access | Times Cited: 29
Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool
David Flood, Elizabeth Edwards, David Giovannini, et al.
Revista Panamericana de Salud Pública (2022) Vol. 46, pp. 1-1
Open Access | Times Cited: 16
HEARTS in the Americas clinical pathway. Strengthening the decision support system to improve hypertension and cardiovascular disease risk management in primary care settings
Andrés Rosende, Donald J. DiPette, Ramón Martínez, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 9
<p>Approaches to the Management of Hypertension in Resource-Limited Settings: Strategies to Overcome the Hypertension Crisis in the Post-COVID Era</p>
Jamario Skeete, Kenneth Connell, Pedro Ordúñez, et al.
Integrated Blood Pressure Control (2020) Vol. Volume 13, pp. 125-133
Open Access | Times Cited: 22
Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development
Magdalena Paczkowska-Walendowska, Szymon Sip, Rafał Staszewski, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4156-4156
Open Access | Times Cited: 13
HEARTS in the Americas appraisal checklist and clinical pathway for comprehensive hypertension management in primary care
Andrés Rosende, Donald J. DiPette, Jeffrey Brettler, et al.
Revista Panamericana de Salud Pública (2022) Vol. 46, pp. 1-1
Open Access | Times Cited: 13
Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review
Truong Van Dat, Vo Linh Tu, Le Nguyen Anh Thu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top